IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 1026-1050 out of 1244.

<< < 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 > >>

Public Release: 1-Apr-2014
Radiology
Digital mammography reduces recall and biopsy rates
Population-based screening with full-field digital mammography is associated with lower recall and biopsy rates than screen film mammography, suggesting that full-field digital mammography may reduce the number of diagnostic workups and biopsies that do not lead to diagnosis of breast cancer, according to a new study.
National Institutes of Health

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America

Public Release: 1-Apr-2014
PLOS Medicine
Screening for liver cancer in patients with cirrhosis
In a systematic review and meta-analysis of 47 studies with 15,158 patients, Amit Singal, University of Texas Southwestern Medical Center, and colleagues found that patients with cirrhosis who underwent surveillance, via liver ultrasound with or without measurement of serum alpha fetoprotein, for hepatocellular carcinoma had cancers detected at an earlier stage, were more likely to receive curative instead of palliative treatment, and had longer survival.
UT-STAR

Contact: Fiona Godwin
medicinepress@plos.org
PLOS

Public Release: 1-Apr-2014
FASEB Journal
The human 'hairless' gene identified: One form of baldness explained
It's not a hair-brained idea: A new research report appearing in the April 2014 issue of The FASEB Journal explains why people with a rare balding condition called 'atrichia with papular lesions' lose their hair, and it identifies a strategy for reversing this hair loss.

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology

Public Release: 1-Apr-2014
JAMA
Medication does not help prevent ED following radiation therapy for prostate cancer
Among men undergoing radiation therapy for prostate cancer, daily use of the erectile dysfunction drug tadalafil, compared with placebo, did not prevent loss of erectile function, according to a study in the April 2 issue of JAMA.

Contact: Joe Dangor
dangor.yusuf@mayo.edu
507-266-0696
The JAMA Network Journals

Public Release: 1-Apr-2014
JAMA
The mammography dilemma
A comprehensive review of 50 years' worth of international studies assessing the benefits and harms of mammography screening suggests that the benefits of the screening are often overestimated, while harms are underestimated.

Contact: David Cameron
david_cameron@hms.harvard.edu
617-432-0441
Harvard Medical School

Public Release: 1-Apr-2014
Journal of Clinical Investigation
Likely culprit in spread of colon cancer identified
New research at Washington University School of Medicine in St. Louis and Vanderbilt University Medical Center in Nashville has implicated a poorly understood protein called PLAC8 in the spread of colon cancer.
National Institutes of Health

Contact: Julia Evangelou Strait
straitj@wustl.edu
314-286-0141
Washington University School of Medicine

Public Release: 1-Apr-2014
Journal of Clinical Oncology
Higher risk of death from skin cancer among men living alone
There are differences in prognosis in cutaneous malignant melanoma depending on cohabitation status and gender, according to a new study published in the scientific periodical Journal of Clinical Oncology. Single men of all ages are more likely to die of their disease.
Swedish Cancer Society, Stockholm County Council, and others

Contact: Press Office
pressinfo@ki.se
46-852-486-077
Karolinska Institutet

Public Release: 1-Apr-2014
JAMA
Experts question routine mammograms in elderly
Doctors should focus on life expectancy when deciding whether to order mammograms for their oldest female patients, since the harms of screening likely outweigh the benefits unless women are expected to live at least another decade, according to a review of the scientific literature by experts at UCSF and Harvard medical schools.

Contact: Laura Kurtzman
laura.kurtzman@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 1-Apr-2014
Cell Metabolism
Obesity primes the colon for cancer, according to NIH study
Obesity, rather than diet, causes changes in the colon that may lead to colorectal cancer, according to a study in mice by the National Institutes of Health. The finding bolsters the recommendation that calorie control and frequent exercise are not only key to a healthy lifestyle, but a strategy to lower the risk for colon cancer, the second leading cause of cancer-related death in the United States.
NIH/National Institute of Environmental Health Sciences

Contact: Robin Arnette
arnetter@niehs.nih.gov
919-541-5143
NIH/National Institute of Environmental Health Sciences

Public Release: 31-Mar-2014
JAMA Internal Medicine
Aspirin use appears linked with improved survival after colon cancer diagnosis
Taking low doses of aspirin (which inhibits platelet function) after a colon cancer diagnosis appears to be associated with better survival if the tumor cells express HLA class I antigen.

Contact: Gerrit Jan Liefers
g.j.liefers@lumc.nl
The JAMA Network Journals

Public Release: 31-Mar-2014
Proceedings of the National Academy of Sciences
Using your loaf to fight brain disease
Experts analyze baker's yeast to discover potential for combating neurological conditions like Parkinson's and even cancer.
Parkinson's United Kingdom, Fundação para a Ciência e Tecnologia Portugal, others

Contact: Flaviano Giorgini
fg36@le.ac.uk
07-505-775-198
University of Leicester

Public Release: 31-Mar-2014
Epidemiology Community Health
Seven a day keeps the reaper at bay
Eating seven or more portions of fruit and vegetables a day reduces your risk of death at any point in time by 42 percent compared to eating less than one portion, reports a new UCL study.

Contact: Harry Dayantis
h.dayantis@ucl.ac.uk
44-020-310-83844
University College London

Public Release: 31-Mar-2014
Oncology Nursing Forum
Mobile tools boost tobacco screening and cessation counseling
Smartphones and tablets may hold the key to getting more clinicians to screen patients for tobacco use and advise smokers on how to quit. Even though tobacco use is the leading cause of preventable disease and death in the US, clinicians often don't ask about smoking during patient exams.
NIH/National Cancer Institute, NIH/National Institute of Nursing Research

Contact: Lisa Rapaport
lr2692@cumc.columbia.edu
212-342-3795
Columbia University Medical Center

Public Release: 31-Mar-2014
Journal of Pathology
Novel study into breast cancer origins paves way for personalized treatment
In a new study published by the Journal of Pathology, Dr. Matt Smalley from Cardiff University treads new ground in exploring what drives breast cancers to look and behave so differently from one another.

Contact: Tomas Llewelyn Barrett
BarrettTL1@cardiff.ac.uk
Cardiff University

Public Release: 31-Mar-2014
International Journal of Oncology
Can vitamin A turn back the clock on breast cancer?
A derivative of vitamin A, known as retinoic acid, helps turn pre-cancer cells back to normal healthy breast cells, explaining why the vitamin may not be helpful for full-blown cancer.

Contact: Edyta Zielinska
edyta.zielinska@jefferson.edu
215-955-5291
Thomas Jefferson University

Public Release: 31-Mar-2014
Nature Genetics
Scientists discover a number of novel genetic defects which cause oesophageal cancer
A team of scientists from the Cancer Science Institute of Singapore at the National University of Singapore and National University Cancer Institute Singapore, and their collaborators from the Cedars-Sinai Medical Centre, UCLA School of Medicine, demonstrated that a number of novel genetic defects are able to induce oesophageal cancer.

Contact: Kimberley Wang
kimberley.wang@nus.edu.sg
65-660-11653
National University of Singapore

Public Release: 31-Mar-2014
Journal of Pediatric Hematology/Oncology
New tool helps young adults with sickle cell disease in the transition to adult care
Child and adolescent hematologists at Boston Medical Center have developed a tool to gauge how ready young adults with sickle cell disease are for a transition into adult care.

Contact: Jenny Eriksen Leary
jenny.eriksen@bmc.org
617-638-6841
Boston University Medical Center

Public Release: 31-Mar-2014
JAMA Pediatrics
Fast food giants' ads for healthier kids meals don't send the right message
Fast food giants attempts at depicting healthier kids' meals frequently goes unnoticed by children ages three to seven years old according to a new study by Dartmouth's Norris Cotton Cancer Center. In research published in JAMA Pediatrics, Dartmouth researchers found that one-half to one-third of children did not identify milk when shown McDonald's and Burger King children's advertising images depicting that product. Sliced apples in Burger King's ads were identified as apples by only 10 percent of young viewers.
Robert Wood Johnson Foundation's Healthy Eating Research Program

Contact: Donna Dubuc
donna.M.Dubuc@Dartmouth.edu
603-653-3615
The Geisel School of Medicine at Dartmouth

Public Release: 31-Mar-2014
BJU International
Certain genetic variants may identify patients at higher risk of bladder cancer recurrence
A new study by Dartmouth researchers suggests that certain inherited DNA sequences may affect a bladder cancer patient's prognosis. These findings may help physicians identify sub-groups of high risk bladder cancer patients who should receive more frequent screenings and aggressive treatment and monitoring.
NIH/National Cancer Institute, National Institutes of Health

Contact: Robin Dutcher
robin.Dutcher@hitchcock.org
603-653-9056
The Geisel School of Medicine at Dartmouth

Public Release: 31-Mar-2014
Proceedings of the National Academy of Sciences
Possible explanation for human diseases caused by defective ribosomes
Mutations in proteins that make ribosomes cause disorders called 'ribosomopathies,' which are characterized by bone marrow failure and anemia early in life, followed by elevated cancer risk in middle age. How can ribosomopathies first appear as diseases caused by too few cells, but later turn into diseases caused by too many cells? This paradox has puzzled the scientific community. A new study suggests ribosomopathies are caused by a sequence of mistakes at the molecular level.
National Institutes of Health

Contact: Heather Dewar
hdewar@umd.edu
301-405-9267
University of Maryland

Public Release: 30-Mar-2014
Nature Genetics
Genetic mutations warn of skin cancer risk
In a study published in Nature Genetics, researchers have discovered that mutations in a specific gene are responsible for a hereditary form of skin cancer. These mutations inactivate the POT1 gene that protects our chromosomes, and, in turn, results in skin cancer. The mechanism that underlies this form of skin cancer is also a potential target for drug development in this subset of melanoma patients.

Contact: Aileen Sheehy
press.office@sanger.ac.uk
44-012-234-92368
Wellcome Trust Sanger Institute

Public Release: 29-Mar-2014
ACMG 2014 Annual Clinical Genetics Meeting
New approach to leukemia testing may better define prognosis, treatment
Nearly half of patients with the most common form of adult leukemia are said to have normal chromosomes but appear instead to have a distinct pattern of genetic abnormalities that could better define their prognosis and treatment, researchers report.

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 28-Mar-2014
ELCC 2014 European Lung Cancer Conference
Call for more awareness of sexual dysfunction in lung cancer patients
Many lung cancer patients suffer difficulties with sexual expression and intimacy, yet for too long the topic has been ignored by doctors and researchers, experts have said at the 4th European Lung Cancer Conference.

Contact: ELCC Press Office
media@esmo.org
European Society for Medical Oncology

Public Release: 28-Mar-2014
Journal of the National Cancer Institute
UNC researchers show cancer chemotherapy accelerates 'molecular aging'
Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging.
National Institutes of Health, Paul Glenn Foundation, Burroughs Wellcome Fund, Breast Cancer Research Foundation

Contact: William Davis
william_davis@med.unc.edu
919-966-5906
University of North Carolina Health Care

Public Release: 28-Mar-2014
Clinical Cancer Research
Gene may predict if further cancer treatments are needed
University of Texas Southwestern Medical Center researchers are developing a new predictive tool that could help patients with breast cancer and certain lung cancers decide whether follow-up treatments are likely to help.

Contact: Patrick McGee
patrick.mcgee@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center

Showing releases 1026-1050 out of 1244.

<< < 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 > >>

  Search News Releases

     

 

 

EurekAlert!